아크로스

ENG
메뉴펼치기

Company History

아크로스의 히스토리를 안내해 드립니다.
2022
  1. 04 Biomaterial graft & prosthesis(medical device) China approval acquisition (Dermalax Deep)
2021
  1. 05 Head office transferred to 3F, 23, Geodudanji 1-gil, Dongnae-myeon, Chuncheon-si, Gangwon-do
2019
  1. 04 Seoul office relocation(4F, 17, Samseong-ro 133-gil, Gangnam-gu, Seoul, Republic of Korea)
2018
  1. 09 Change Representative Director,
2016
  1. 01 Established Seoul Office (No.1702, 514, Seolleung-ro, Gangnam-gu, Seoul (Samsungdong, Seongwon building))
  2. 01 Anyang branch closed
  3. 01 Head office transferred to 4F, Laboratory, 23, Geodudanji 1-gil, Dongnae-myeon, Chuncheon-si, Gangwon-do
  4. 08 Registered patent for 'Method of manufacturing dental bone filler containing crosslinked hyaluronic acid' (No. 10-1650414)
2015
  1. 05 Acquired CE certification for biomaterial graft & prosthesis including lidocaine for the first time in Republic of Korea .
  2. 09 Changed the largest shareholder (Hugel Inc.)
2014
  1. 01 Moved to No. 503 and No.504, Gwanyang Dusan Venture Dime in Anyang
  2. 04 Registered Chuncheon branch and business registration
  3. 04 Biomaterial graft & prosthesis(medical device) MFDS Authorization of manufacturing product(The Chaeum)
  4. 05 Biomaterial graft & prosthesis(medical device) MFDS manufacturing approval for export acquisition (Chunchen)
  5. 05 KGMP acquisition of Anyang medical device manufacturing factory
  6. 08 KGMP acquisition Chuncheon medical device manufacturing factory
  7. 10 Biomaterial graft & prosthesis(medical device) MFDS acquired authorization of manufacturing product, No.14-1762
2013
  1. 06 Biomaterial graft & prosthesis(medical device) MFDS manufacturing approval for export acquisition (Volus with lidocaine)
  2. 06 Registered ‘Revolax’ trademark (No. 40-0975203)
  3. 07 Biomaterial graft & prosthesis(medical device) MFDS manufacturing approval for export acquisition (Volus)
  4. 09 Biomaterial graft & prosthesis(medical device) MFDS manufacturing approval for export acquisition (Dermalax with lidocaine)
  5. 12 Daegu branch closed (transferred to head office)
  6. 12 Registered 'Volus' trademark (No. 40-41014852)
2012
  1. 01 Established affiliated research institute
  2. 02 Dermalax Deep CE/ISO13485 Acquisition
  3. 03 Biomaterial graft & prosthesis(medical device) MFDS manufacturing approval for export acquisition (Dermalax series)
  4. 04 Acquired certification of venture verification company
  5. 05 Daegu medical device manufacturing plant acquired KGMP
2011
  1. 03 Medical device manufacturing license (No. 3393)
  2. 04 Daegu medical device manufacturing facility construction
  3. 04 Establishment of Daegu branch registration and business registration
  4. 07 Biomaterial graft & prosthesis(medical device) MFDS manufacturing approval for export acquisition (Dermalax/Revolax)
2009
  1. 04 Established TW Life Science
  2. 06 Moved to Gyeonggi Venture Anyang Science College Center
  3. 06 Changed company name into Across Co., Ltd.
2022
  1. 04 Biomaterial graft & prosthesis(medical device) China approval acquisition (Dermalax Deep)
2021
  1. 05 Head office transferred to 3F, 23, Geodudanji 1-gil, Dongnae-myeon, Chuncheon-si, Gangwon-do
2019
  1. 04 Seoul office relocation(4F, 17, Samseong-ro 133-gil, Gangnam-gu, Seoul, Republic of Korea)
2018
  1. 09 Change Representative Director,
2016
  1. 01 Established Seoul Office (No.1702, 514, Seolleung-ro, Gangnam-gu, Seoul (Samsungdong, Seongwon building))
  2. 01 Anyang branch closed
  3. 01 Head office transferred to 4F, Laboratory, 23, Geodudanji 1-gil, Dongnae-myeon, Chuncheon-si, Gangwon-do
  4. 08 Registered patent for 'Method of manufacturing dental bone filler containing crosslinked hyaluronic acid' (No. 10-1650414)
2015
  1. 05 Acquired CE certification for biomaterial graft & prosthesis including lidocaine for the first time in Republic of Korea .
  2. 09 Changed the largest shareholder (Hugel Co., Ltd.)
2014
  1. 01 Moved to No. 503 and No.504, Gwanyang Dusan Venture Dime in Anyang
  2. 04 Registered Chuncheon branch and business registration
  3. 04 Biomaterial graft & prosthesis(medical device) MFDS Authorization of manufacturing product(The Chaeum)
  4. 05 Biomaterial graft & prosthesis(medical device) MFDS manufacturing approval for export acquisition (Chunchen)
  5. 05 KGMP acquisition of Anyang medical device manufacturing factory
  6. 08 KGMP acquisition Chuncheon medical device manufacturing factory
  7. 10 Biomaterial graft & prosthesis(medical device) MFDS acquired authorization of manufacturing product, No.14-1762
2013
  1. 06 Biomaterial graft & prosthesis(medical device) MFDS manufacturing approval for export acquisition (Volus with lidocaine)
  2. 06 Registered ‘Revolax’ trademark (No. 40-0975203)
  3. 07 Biomaterial graft & prosthesis(medical device) MFDS manufacturing approval for export acquisition (Volus)
  4. 09 Biomaterial graft & prosthesis(medical device) MFDS manufacturing approval for export acquisition (Dermalax with lidocaine)
  5. 12 Daegu branch closed (transferred to head office)
  6. 12 Registered 'Volus' trademark (No. 40-41014852)
2012
  1. 01 Established of affiliated research institute
  2. 02 Dermalax Deep CE/ISO13485 Acquisition
  3. 03 Biomaterial graft & prosthesis(medical device) MFDS manufacturing approval for export acquisition (Dermalax series)
  4. 04 Acquired certification of venture verification company
  5. 05 Daegu medical device manufacturing plant acquired KGMP
2011
  1. 03 Medical device manufacturing license (No. 3393)
  2. 04 Daegu medical device manufacturing facility construction
  3. 04 Establishment of Daegu branch registration and business registration
  4. 07 Biomaterial graft & prosthesis(medical device) MFDS manufacturing approval for export acquisition (Dermalax/Revolax)
2009
  1. 04 Established TW Life Science
  2. 06 Moved to Gyeonggi Venture Anyang Science College Center
  3. 06 Changed company name into Across Co., Ltd.